HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients
Shoskes, D.A.; Hodge, E.E.; Goormastic, M.; Goldfarb, D.A.; Novick, A.C.
Transplantation Proceedings 27(1): 1068-1069
1995
ISSN/ISBN: 0041-1345 PMID: 7878808 Document Number: 441349
Document emailed within 1 workday
Related Documents
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Kimball, P.M.; King, A. 2011: A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients Clinical Transplants 2011: 369-372
Harmon, W.E.; Stablein, D.; Alexander, S.R.; Tejani, A. 1991: Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study Transplantation 51(2): 406-412
Potena, L.; Grigioni, F.; Magnani, G.; Sorbello, S.; Sassi, S.; Marinucci, L.; Conti, R.; Carinci, V.; Leone, O.; Arpesella, G.; Coccheri, S.; Magelli, C.; Branzi, A. 2000: Increasing plasma homocysteine during follow-up in heart transplant recipients: effects of folate and renal function Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(5): 344-348
Hardy, B.; Cicciarelli, J.C.; Iwaki, Y.; Shaul, D.; Mendez, R. 1995: Parameters governing graft survival in pediatric renal transplant recipients Transplantation Proceedings 27(1): 1086-1088
Pirsch, J.D.; Voss, B.J.; Roecker, E.B.; Lorentzen, D.F.; Knechtle, S.J.; Reed, A.; D'Alessandro, A.M.; Sollinger, H.W.; Kalayoglu, M.; Belzer, F.O. 1991: Predictive factors for immunologic graft failure in cadaver renal transplant recipients Transplantation Proceedings 23(1 Part 2): 1282-1283
Susen, S.; Hazzan, M.; Labalette, M.; Zawadzki, C.; Dessaint, J.P.; Lelièvre, G.; Jude, B.; Noël, C. 2000: Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complications Thrombosis and Haemostasis 84(5): 764-769
Mendez, R.; Mendez, R.G.; Cicciarelli, J.; Meihaus, J.; Boken, R.; Bogaard, T.; Chaballout, A. 1991: Matching, race, donor age, and cold ischemia effects at a single renal transplant center Transplantation Proceedings 23(1 Part 1): 376-377
Ivanovski, N.; Stojceva-Taneva, O.; Grozdanovski, R.; Boskovska, M.; Drueke, T.B.; Massy, Z.A. 2004: Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment Nephrologie 25(7): 301-303
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Zanker, B.; Barth, C.; Menges, A.V.; Lammerding, P.; Stachowski, J.; Baldamus, C.A. 1995: Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft Transplantation Proceedings 27(1): 925-926
Busson, M.; Hors, J.; Prevost, P.; Raffoux, C.; Betuel, H.; Bignon, J.D.; Tongio, M.M.; Seignalet, J.; Calot, M.; Lepetit, J.C. 1988: Importance of HLA-A, -B and -DR matching in presensitized kidney transplant recipients Clinical Transplants 1988: 199-202
Ovuworie, C.A.; Fox, E.R.; Chow, C.M.; Pascual, M.; Shih, V.E.; Picard, M.H.; Tolkoff-Rubin, N.E. 2001: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients Transplantation 72(8): 1385-1388
Cicciarelli, J.; Shah, T.; Koss, M.; Houston, K.; Narahghi, R. 2006: Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA) Clinical Transplants 2006: 539-540
Warino, L.; Libecco, J. 2006: Cutaneous effects of sirolimus in renal transplant recipients Journal of Drugs in Dermatology: Jdd 5(3): 273-274
Laine, J.; Holmberg, C. 1996: Tubular effects of cyclosporine in pediatric renal transplant recipients Transplantation Proceedings 28(4): 2104-2106
Langley, J.; Vergne-Marini, P.; Dickerman, R.M.; Brinker, K.R.; Land, G. 1991: Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts Transplantation Proceedings 23(2): 1757-1759
Redlich, P.N.; Leapman, S.B.; Marder, P.; Schmidtke, J.; Smith, E.J.; Fineberg, N.; Filo, R.S. 1984: Evaluation of lymphocyte subsets and suppressor cell function in long-term renal transplant recipients Transplantation Proceedings 16(6): 1555-1557
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375